scispace - formally typeset
J

Jerrold M. Olefsky

Researcher at University of California, San Diego

Publications -  606
Citations -  83310

Jerrold M. Olefsky is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Insulin & Insulin resistance. The author has an hindex of 143, co-authored 595 publications receiving 77356 citations. Previous affiliations of Jerrold M. Olefsky include University of Colorado Boulder & University of Michigan.

Papers
More filters
Journal ArticleDOI

The signaling pathway coupling epidermal growth factor receptors to activation of p21ras.

TL;DR: Data indicate that coupling to Shc provides the major pathway linking activated EGFRs to Grb2.Sos and stimulation of the p21ras pathway.
Journal ArticleDOI

Inhibition of Phosphatidylinositol 3-Kinase Activity by Adenovirus-mediated Gene Transfer and Its Effect on Insulin Action

TL;DR: It is concluded that, in 3T3-L1 adipocytes, non-IRS-1-associated PI 3-kinase activity is crucial for insulin’s metabolic signaling, and that overexpressed p85N-SH2 protein inhibits a variety of insulin's ultimate biological effects.
Journal ArticleDOI

Insulin receptor substrate 1 is required for insulin-mediated mitogenic signal transduction.

TL;DR: Microinjection of anti-IRS-1 antibody completely inhibited incorporation of bromodeoxyuridine into the nuclei of cells stimulated with insulin or insulin-like growth factor I but did not affect cells stimulating with serum or a variety of purified growth factors.
Journal ArticleDOI

Role of Glucose Transport in the Postreceptor Defect of Non-insulin-dependent Diabetes Mellitus

TL;DR: The insulin resistance in subjects with IGT is due solely to a decrease in insulin binding, whereas subjects with NIDDM exhibit both decreased insulin binding and decreased maximal rates of insulin-stimulated adipocyte glucose transport due to a postreceptor defect at this site in the insulin action pathway.
Journal ArticleDOI

Effect of Troglitazone on Leptin Production: Studies In Vitro and in Human Subjects

TL;DR: It appears that obese subjects are resistant to the effects of endogenously secreted leptin, as there was no significant change in fasting plasma leptin concentrations, despite a 40–50% reduction in fasting and postmeal plasma insulin concentrations.